Funds

TimeFunding agencyTitleAmount
2002-2006DFG, Junior group grant within the collaborative research center 405The regulation of Natural Killer cells – lessons learned from the 2B4 (CD244) receptor1,2 Mio Euro
2005-2007German Cancer FoundationIdentification of the ligands for the ’natural cytotoxicity receptors‘ NKp30, NKp44 und NKp46124 000 Euro
2005-2011German Ministry for Science and Education (BMBF)-BioFutureThe role of lipid rafts in the activation and function of human Natural Killer cells1,5 Mio Euro
2006-2009DFG, Subproject A13 within the collaborative research center 405Modulation of lymphocyte activities by SLAM-related receptors506 000 Euro
2007-2008German Cancer FoundationRole of SLAM family receptors in the activation of gamma/delta T cells153 000 Euro collaborative grant together with Prof. A. Märten
2007-2011German Ministry for Science and Education (BMBF)-Systems Biology of Cancer (SBCancer)Cellular Decisions in Natural Killer cells251 000 Euro
2009DFG, Individual grantIdentification and functional characterization of proteins associated with membrane fractions surrounding activating and inhibitory Natural Killer cell receptors212 000 Euro
2008-2010German Cancer FoundationIdentification of the ligands for the ’natural cytotoxicity receptors‘ NKp30, NKp44 und NKp46130 000 Euro
2008-2011Graduate Academy of the state Baden WürttembergDifferential activation and integration of signaling modules within the immune system1 PhD student stipend
2010-2013DFG, Subproject 16 within the transregional collaborative research center (TRR) 83Identification and functional characterization of proteins associated with membrane fractions surrounding activating and inhibitory Natural Killer cell receptors369 000 Euro
2010-2013University of Regensburg, DFG funded grant CA933/1-1) within the research unit FOR696 – Molecular Analyses and Interactions at Articular InterfacesRole of tyrosine hydroxylase (TH) – positive cells in arthritisapprox. 335 000 Euro
2011- 2013DFG, Individual grant‚SLAM-related receptors‘: role of the cis/trans interaction in the regulation of Natural Killer cells and function on T cells162 000 Euro
2013- 2016Leibniz SAW ProcedureDefining Natural Killer Cell reactivity by quantitative analysis of activating and inhibitory receptor signal integration819 000 Euro
2015-2016Start-up price funded by the DGRhThe dopamine pathway: a potential therapeutic target for local treatment of rheumatoid arthritis40 700 Euro
2016-2018MARIE CURIE individual Fellowship (EU Horizon2020)Dopamine and bone metabolism in rheumatoid arthritis171 000 Euro